Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy

Qiqi Liu,1,* Pingping Hu,1,* Guodong Deng,1 Jingxin Zhang,2 Ning Liang,1 Jian Xie,1 Lili Qiao,3 Hui Luo,4 Jiandong Zhang1 1Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Shandong University, Jinan, 2Division of Oncology, Department of Graduate, Weifang Medi...

Full description

Bibliographic Details
Main Authors: Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:OncoTargets and Therapy
Subjects:
Soluble cytotoxic T lymphocyte antigen 4
immunotherapy
survival
cancer therapy
cancer prognosis.
Online Access:https://www.dovepress.com/soluble-cytotoxic-t-lymphocyte-antigen-4-a-favorable-predictor-in-mali-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/soluble-cytotoxic-t-lymphocyte-antigen-4-a-favorable-predictor-in-mali-peer-reviewed-article-OTT

Similar Items